
Opinion|Videos|June 21, 2024
Navigating First-Line Treatment Choices for Metastatic Urothelial Carcinoma
Author(s)Pedro Barata, MD, MSc, FACP
A medical professional outlines their preferred first-line treatment strategy for managing patients diagnosed with metastatic urothelial carcinoma, providing valuable insights into their clinical decision-making process.
Advertisement
Episodes in this series

- What is your standard first-line treatment approach for metastatic urothelial carcinoma, including factors considered in choosing treatment?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
NCCN Updates Breast Cancer Guidelines: Sacituzumab Govitecan for 1L TNBC
2
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
3
FDA Grants FTD to GPRC5D Bispecific LBL-034 for R/R Multiple Myeloma
4
Multiomic Real-World Data Predict Outcomes in Metastatic Breast Cancer
5


















